CTRI/2019/06/019845已完成3 期
Efficacy and safety of add-on Rupatadine treatment for Chronic low back pain- An assessor blind randomized controlled clinical study-A pilot study
试验速览
- 阶段
- 3 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age group 18-60 years
- •2. Subjects with Chronic Low Back Pain more than three months, Visual analog scale more than 40 mm
- •3. Both genders
- •4. Patients willing to give consent
排除标准
- •1. History of acute fracture
- •2. History of malignancy or neurological deficit or severe leg pain mandating surgery
- •3. History of lumbar disc herniation or spinal stenosis
- •4. History of fibromyalgia or spinal surgery
- •5. History of recent trauma or injury
- •6. History of alcohol or narcotic abuse
- •7. History of Peptic ulcer disease or hepatic and renal dysfunction
- •8. History of heart surgery
- •9. History of Allergy to Aceclofenac CR or H1 antagonists
- •10. Pregnant,lactating women
- •11. Psychiatric disorders
研究者
相似试验
已完成
3 期
â??A clinical trial to study the beneficial effects of the drug â??â??Rupatadineâ?? in â??â??Allergic skin diseaseCTRI/2017/05/008624SRM University
进行中（未招募）
不适用
To learn more about a medicine called rupatadine, in treatment of urticarial itchy wheals in children (2-11 years old).EUCTR2010-023057-11-HUJ. Uriach y Compañía, S.A.192
已完成
不适用
Evaluation of the clinical usefulness of rupatadine in patients with seasonal allergic rhinitisSeasonal allergic rhinitisJPRN-UMIN000031360Medical Corporation Shinanokai, Shinanozaka Clinic100
进行中（未招募）
不适用
Efficacy and safety of rupatadine in persistent allergic rhinitis and health-related quality of life in children age 6-11 years: A randomized, double blind, placebo-controlled clinical trial.EUCTR2008-005939-15-HUJ. Uriach y Compañía, S.A.366
终止
2 期
Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic UrticariaURTICARIANCT00199238J. Uriach and Company248